| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | L01DB11 |
| UNII: | F5SXN2KNMR |
Structure
| InChI Key | PEZPMAYDXJQYRV-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C17H19N5O2 |
| Molecular Weight | 325.37 |
| AlogP | 0.6 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 123.13 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 24.0 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Related Entries
MCS
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 144510-96-3 |
| ChEBI | 135945 |
| ChEMBL | CHEMBL167731 |
| DrugBank | DB06193 |
| DrugCentral | 4330 |
| EPA CompTox | DTXSID10162744 |
| FDA SRS | F5SXN2KNMR |
| Guide to Pharmacology | 7544 |
| PubChem | 134019 |
| SureChEMBL | SCHEMBL7825 |
| ZINC | ZINC000001535903 |
CONTENTS